Further, apabetalone diminished the production of pro-inflammatory cytokines (TNF-α and IL-1β) in hyper-responsive monocytes isolated from diabetic patients with cardiovascular disease [42]. The gene discussed is IL1B; the disease is cardiovascular disorder.